Corindus Vascular Robotics Inc (CVRS) 4.2500 $CVRS
Corindus Vascular Robotics, Inc. to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Fri Feb 06, 2:31PM CST
Corindus Vascular Robotics, Inc. [OTCQB: CVRS], a leading developer of precision vascular robotics, announced today that its CEO, David M. Handler, will present at the 2015 Leerink Global Healthcare Conference on February 11 at 8:50am EST at The Waldorf Astoria Hotel in New York City.
Corindus Vascular Robotics, Inc. to Present at Stifel 2014 Healthcare Conference
Business Wire - Tue Nov 18, 10:37AM CST
Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics ("Corindus" or the "Company"
, announced today that its CEO, David M. Handler, will present at the Stifel 2014 Healthcare Conference on Wednesday, November 19 at 2:25pm EST at the New York Palace Hotel.
Corindus Vascular Robotics, Inc. Closes Private Placement for $26.6 Million
Business Wire - Fri Sep 12, 12:19PM CDT
Corindus Vascular Robotics, Inc. [OTCQB: CVRS], a leading developer of precision vascular robotics ("Corindus" or the "Company" , announced today that it entered into a Securities Purchase Agreement pursuant to which the Company will issue and sell to certain accredited investors an aggregate of 10,666,570 shares of the Company's Common Stock in a private placement at a purchase price of $2.50 per share, resulting in aggregate gross proceeds to the Company of approximately $26.6 million. The Company has agreed to file a registration statement covering the resale of all shares issued in the private placement.
Corindus Vascular Robotics Highlights Radiation Reduction at TCT Meeting
Business Wire - Thu Sep 11, 7:01AM CDT
Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics, will showcase its CorPath(C) Vascular Robotic System during the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting, September 13 - 17 in Washington, D.C. Throughout the meeting, Corindus will highlight occupational safety and robotic precision during percutaneous coronary intervention (PCI) procedures, including radiation exposure reduction by robotic-assisted PCI.
Radiation Reduction During Robotic-Assisted PCI to Be Highlighted at TCT 2014
Business Wire - Wed Sep 03, 7:01AM CDT
--"Robotic PCI: Precision and Protection from Occupational Hazards"
Corindus Vascular Robotics, Inc. to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Fri Feb 06, 2:31PM CST
Corindus Vascular Robotics, Inc. [OTCQB: CVRS], a leading developer of precision vascular robotics, announced today that its CEO, David M. Handler, will present at the 2015 Leerink Global Healthcare Conference on February 11 at 8:50am EST at The Waldorf Astoria Hotel in New York City.
Corindus Vascular Robotics, Inc. to Present at Stifel 2014 Healthcare Conference
Business Wire - Tue Nov 18, 10:37AM CST
Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics ("Corindus" or the "Company"
, announced today that its CEO, David M. Handler, will present at the Stifel 2014 Healthcare Conference on Wednesday, November 19 at 2:25pm EST at the New York Palace Hotel. Corindus Vascular Robotics, Inc. Closes Private Placement for $26.6 Million
Business Wire - Fri Sep 12, 12:19PM CDT
Corindus Vascular Robotics, Inc. [OTCQB: CVRS], a leading developer of precision vascular robotics ("Corindus" or the "Company"
, announced today that it entered into a Securities Purchase Agreement pursuant to which the Company will issue and sell to certain accredited investors an aggregate of 10,666,570 shares of the Company's Common Stock in a private placement at a purchase price of $2.50 per share, resulting in aggregate gross proceeds to the Company of approximately $26.6 million. The Company has agreed to file a registration statement covering the resale of all shares issued in the private placement. Corindus Vascular Robotics Highlights Radiation Reduction at TCT Meeting
Business Wire - Thu Sep 11, 7:01AM CDT
Corindus Vascular Robotics, Inc. (OTCQB: CVRS), a leading developer of precision vascular robotics, will showcase its CorPath(C) Vascular Robotic System during the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting, September 13 - 17 in Washington, D.C. Throughout the meeting, Corindus will highlight occupational safety and robotic precision during percutaneous coronary intervention (PCI) procedures, including radiation exposure reduction by robotic-assisted PCI.
Radiation Reduction During Robotic-Assisted PCI to Be Highlighted at TCT 2014
Business Wire - Wed Sep 03, 7:01AM CDT
--"Robotic PCI: Precision and Protection from Occupational Hazards"
